Madrigal Pharmaceuticals Inc.
MDGL | NASDAQ
$521.96
-$9.56 (-1.80%)
At close: Sep 21, 2026, 4:00 PM ET
$521.96
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $12.28B
Enterprise Value $11.57B
Beta -0.99
Average Volume 330.41K
Shares Outstanding (Diluted) 29.15M
Shares Change YoY 31.24%
Institutional Ownership 81.89%
Exchange NASDAQ
ISIN US5588681057
Price Performance
Price Change 1M 1.0%
Price Change 3M 1.7%
Price Change 6M 13.0%
Price Change YTD -12.1%
Price Change 1Y 18.6%
Price Change 3Y 240.4%
Price Change 5Y 514.9%
1M CAGR (ann.) 4.2%
1Y CAGR (ann.) 27.3%
5Y CAGR (ann.) 46.0%
All-Time CAGR 2.6%
Valuation
PE Ratio -40.49
Forward PE 174.35
PEG Ratio 119.46
Forward PEG 0.20
PS Ratio 9.39
Forward PS 5.60
PB Ratio 23.03
P/FCF Ratio -58.46
P/Adj. FCF Ratio -39.94
P/OCF Ratio -76.99
EV/Sales 9.01
EV/EBIT -38.57
EV/EBITDA -38.72
EV/FCF -56.08
Earnings Yield -2.5%
FCF Yield -1.7%
Adj. FCF Yield -2.5%
Financial Health
Net Cash $496.93M
Total Debt $347.75M
Cash & Short-Term Investments $838.75M
Total Assets $1.24B
Current Ratio 3.20
Quick Ratio 2.94
Debt / Equity Ratio 0.66
Debt / EBITDA -1.16
Debt / FCF -1.69
OCF / Debt -0.57
Interest Coverage -20.64
Altman Z-Score 8.73
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 91.5%
Operating Profit Margin -25.1%
EBITDA Margin -23.3%
Net Profit Margin -25.3%
FCF Margin -16.1%
Adj. FCF Margin -23.5%
SBC / Revenue 7.5%
SBC Impact (per share) -46.4%
Returns
Return on Assets -26.1%
Return on Equity -56.6%
Return on Invested Capital -37.0%
Return on Capital Employed -37.1%
Return on Tangible Assets -26.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 105.0%
Revenue CAGR 5Y 85.0%
Revenue CAGR 10Y 50.9%
EPS CAGR 3Y 36.9%
EPS CAGR 5Y 6.0%
EPS CAGR 10Y -15.4%
FCF CAGR 3Y 38.6%
FCF CAGR 5Y -1.4%
FCF CAGR 10Y -22.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 25
EPS Growth Next 3Y 133.5%
Revenue Growth Next 3Y 43.6%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $677
Price Target Upside 29.7%
Cash Flow
Operating Cash Flow $-197.72M
Free Cash Flow $-206.29M
Adj. Free Cash Flow $-301.93M
FCF Per Share -$7.08
OCF Per Share -$6.78
OCF/S Ratio -15.4%
Income Statement
Revenue $1.28B
Gross Profit $1.17B
Operating Income $-322.62M
EBITDA $-298.76M
Net Income $-325.1M
EPS (Diluted) -$12.89
Revenue / Employee $1.4M
Profit / Employee $-355.3K
Employees 915
Add to Watchlist
Select watchlists to add or remove MDGL